journal article·2011-09

Effect of serum proteins on polystyrene nanoparticle uptake and intracellular trafficking in endothelial cells

Daniela Guarnieri, Angela Guaccio, Sabato Fusco, Paolo A. Netti

Journal of Nanoparticle Research· Volume 13· Issue 9
Publisher page

Abstract

The physico-chemical properties of nanoparticles (NPs), such as small dimensions, surface charge and surface functionalization, control their capability to interact with cells and, in particular, with sub-cellular components. This interaction can be also influenced by the adsorption of molecules present in biological fluids, like blood, on NP surface. Here, we analysed the effect of serum proteins on 49 and 100 nm red fluorescent polystyrene NP uptake in porcine aortic endothelial (PAE) cells, as a model for vascular transport. To this aim, NP uptake kinetic, endocytic pathway and intracellular trafficking were studied by monitoring NPs inside cells through confocal microscopy and multiple particle tracking (MPT). We demonstrated that NPs are rapidly internalized by cells in serum-free (SF) medium, according to a saturation kinetic. Conversely, in 10% foetal bovine serum-enriched (SE) medium, NP uptake rate results drastically reduced. Moreover, NP internalization depends on an active endocytic mechanism that does not involve clathrin- and caveolae-mediated vesicular transport, in both SE and SF media. Furthermore, MPT data indicate that NP intracellular trafficking is unaffected by protein presence. Indeed, approximately 50–60% of internalized NPs is characterized by a sub-diffusive behaviour, whereas the remaining fraction shows an active motion. These findings demonstrate that the unspecific protein adsorption on NP surface can affect cellular uptake in terms of internalization kinetics, but it is not effective in controlling active and cellular-mediated uptake mechanisms of NPs and their intracellular routes.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Polymer Surface Interaction Studies · Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E (2002) Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99(20):12617–1262110.1073/pnas.152463399 ↗
2. Blocker A, Severin FF, Burkhardt JK, Bingham JB, Yu H, Olivo JC, Schroer TA, Hyman AA, Griffiths G (1997) Molecular requirements for bi-directional movement of phagosomes along microtubules. J Cell Biol 137(1):113–12910.1083/jcb.137.1.113 ↗
3. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56(11):1649–165910.1016/j.addr.2004.02.014 ↗
4. Caspi A, Yeger O, Grosheva I, Bershadsky AD, Elbaum M (2001) A new dimension in retrograde flow: centripetal movement of engulfed particles. Biophys J 81(4):1990–200010.1016/S0006-3495(01)75849-3 ↗
5. Chithrani BD, Ghazani AA, Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4):662–66810.1021/nl052396o ↗
6. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37–4410.1038/nature01451 ↗
7. de Gennes PG (1976) La percolation: Un concept unificateur. La Recherche 7(72):919–927
8. Decuzzi P, Ferrari M (2006) The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27(30):5307–531410.1016/j.biomaterials.2006.05.024 ↗
9. Decuzzi P, Ferrari M (2007) The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 28(18):2915–292210.1016/j.biomaterials.2007.02.013 ↗
10. Decuzzi P, Ferrari M (2008) Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 29(3):377–38410.1016/j.biomaterials.2007.09.025 ↗
11. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of biodegradable microparticles in caco-2 cells is size dependent. Pharm Res 14(11):1568–157310.1023/A:1012126301290 ↗
12. Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857–90210.1146/annurev.biochem.78.081307.110540 ↗
13. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL (2009) The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30(4):603–61010.1016/j.biomaterials.2008.09.050 ↗
14. Ewers H, Smith AE, Sbalzarini IF, Lilie H, Koumoutsakos P, Helenius A (2005) Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes. Proc Natl Acad Sci USA 102(42):15110–1511510.1073/pnas.0504407102 ↗
15. Gbadamosi JK, Hunter AC, Moghimi SM (2002) Pegylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance. FEBS Lett 532(3):338–34410.1016/S0014-5793(02)03710-9 ↗
16. Golding I, Cox EC (2006) Physical nature of bacterial cytoplasm. Phys Rev Lett 96(9):09810210.1103/PhysRevLett.96.098102 ↗
17. Harush-Frenkel O, Debotton N, Benita S, Altschuler Y (2007) Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun 353:26–3210.1016/j.bbrc.2006.11.135 ↗
18. Hillaireau H, Couvreur P (2009) Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66(17):2873–289610.1007/s00018-009-0053-z ↗
19. Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, Orr BG, Baker JR Jr, Banaszak Holl MM (2006) Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem 17(3):728–73410.1021/bc060077y ↗
20. Huang M, Ma Z, Khor E, Lim L (2002) Uptake of FITC chitosan nanoparticles by A549 cells. Pharm Res 19:1488–149410.1023/A:1020404615898 ↗
21. Jiang W, Kim BY, Rutka JT, Chan WC (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3(3):145–15010.1038/nnano.2008.30 ↗
22. Jin H, Heller DA, Strano MS (2008) Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in nih-3t3 cells. Nano Lett 8(6):1577–158510.1021/nl072969s ↗
23. Johnston HJ, Semmler-Behnke M, Brown DM, Kreyling W, Tran L, Stone V (2010) Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. Toxicol Appl Pharmacol 242(1):66–7810.1016/j.taap.2009.09.015 ↗
24. Kim W, Choi HC, Shim M, Li Y, Wang D, Dai H (2002) Synthesis of ultralong and high percentage of semiconducting single-walled carbon nanotubes. Nano Lett 2(7):703–70810.1021/nl025602q ↗
25. Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ (1998) Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J Pharm Sci 87(10):1229–123410.1021/js980021f ↗
26. Lai SK, Hida K, Man ST, Chen C, Machamer C, Schroer TA, Hanes J (2007) Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials 28(18):2876–288410.1016/j.biomaterials.2007.02.021 ↗
27. Lai SK, Hida K, Chen C, Hanes J (2008) Characterization of the intracellular dynamics of a non-degradative pathway accessed by polymer nanoparticles. J Control Release 125(2):107–11110.1016/j.jconrel.2007.10.015 ↗
28. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ (2005) Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentration. Environ Sci Technol 39(23):9370–937610.1021/es051043o ↗
29. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105(38):1426510.1073/pnas.0805135105 ↗
30. Mao S, Germershaus O, Fischer D, Linn T, Schnepf R, Kissel T (2005) Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm Res 22:2058–206810.1007/s11095-005-8175-y ↗
31. Mineo C, Anderson RG (2001) Potocytosis Robert feulgen lecture. Histochem Cell Biol 116(2):109–11810.1007/s004180100289 ↗
32. Muro S, Koval M, Muzykantov V (2004) Endothelial endocytic pathways: gates for vascular drug delivery. Curr Vasc Pharmacol 2(3):281–29910.2174/1570161043385736 ↗
33. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):82310.1289/ehp.7339 ↗
34. Owens DE III, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307(1):93–10210.1016/j.ijpharm.2005.10.010 ↗
35. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55(3):329–34710.1016/S0169-409X(02)00228-4 ↗
36. Panyam J, Labhasetwar V (2004) Targeting intracellular targets. Curr Drug Deliv 1(3):235–24710.2174/1567201043334768 ↗
37. Peetla C, Labhasetwar V (2008) Biophysical characterization of nanoparticle-endothelial model cell membrane interactions. Mol Pharm 5(3):418–42910.1021/mp700140a ↗
38. Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH (2003) Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in plga nanoparticle endocytosis. Mol Vis 9:559–568
39. Rappoport JZ (2008) Focusing on clathrin-mediated endocytosis. Biochem J 412(3):415–42310.1042/BJ20080474 ↗
40. Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377(Pt 1):159–16910.1042/bj20031253 ↗
41. Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr P (2006) Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 40(14):4353–435910.1021/es0522635 ↗
42. Sbalzarini IF, Koumoutsakos P (2005) Feature point tracking and trajectory analysis for video imaging in cell biology. J Struct Biol 151(2):182–19510.1016/j.jsb.2005.06.002 ↗
43. Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, Ferrari M (2009) The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 30(13):2440–244810.1016/j.biomaterials.2009.01.019 ↗
44. Stan RV (2002) Structure and function of endothelial caveolae. Microsc Res Tech 57(5):350–36410.1002/jemt.10089 ↗
45. Swanson JA, Watts C (1995) Macropinocytosis. Trends Cell Biol 5(11):424–42810.1016/S0962-8924(00)89101-1 ↗
46. Tantra R, Tompkinsa J, Quinceya P (2010) Characterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspension. Colloids Surf B Biointerfaces 75(1):275–28110.1016/j.colsurfb.2009.08.049 ↗
47. Tolic-Norrelykke IM, Munteanu EL, Thon G, Oddershede L, Berg-Sorensen K (2004) Anomalous diffusion in living yeast cells. Phys Rev Lett 93(7):07810210.1103/PhysRevLett.93.078102 ↗
48. Verma A, Uzun O, Hu Y, Hu Y, Han HS, Watson N, Chen S, Irvine DJ, Stellacci F (2008) Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater 7(7):588–59510.1038/nmat2202 ↗
49. Wang Z, Tiruppathi C, Minshall RD, Malik AB (2009) Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano 3(12):4110–411610.1021/nn9012274 ↗
50. Xia T, Rome L, Nel A (2008) Nanobiology: particles slip cell security. Nat Mater 7(7):519–52010.1038/nmat2213 ↗
51. Yacobi NR, Malmstadt N, Fazlollahi F, DeMaio L, Marchelletta R, Hamm-Alvarez SF, Borok Z, Kim KJ, Crandall ED (2010) Mechanisms of alveolar epithelial translocation of a defined population of nanoparticles. Am J Respir Cell Mol Biol 42(5):604–61410.1165/rcmb.2009-0138OC ↗